European pharmaceutical Has been confirmed in a statement Those that are often used to treat alopecia, This can result in a potential side effect of suicide.
As the European agency announces, The frequency of this side effect is unknownThat is, it cannot be assessed from the data available so far.
Potential risk
This notice is prepared within the structure of a review in the European Union of Available Data on Finished and Tatarida Drugs. It should be noted that this drug is likely Already includes a warning About the risk of humor changes, including depression, depression mood and suicide. In addition, patients who experience complications in sexual activity (such as Lipido or Lipness) Label warns the need to resort to medical service, as they are known as other known effects of the drug and they can contribute to suicidal ideas.
Most cases of suicide intention 1 M.G. Tablets are recorded in those who carry tablets through the phenteride, which are usually used to treat androgenic alopecia (ie, hair loss due to the process of male sex hormones). On the contrary, other drug presentations (5 mg or 0.5 mg) in the treatment of harmless prostate hypertex Placesia.
As for its page, it could not be installed The link between suicide intention and tatarida Based on EMA reviewed data. However, the agency warns that it works the same as finasaride, so information on potential changes in the mood as a precautionary measure will be added to its expectation.
Eventually, patients who take some medications in addition to adding this data in the possibilities of the drug Look at medical attention If they experience mood problems, depression conditions, suicides or other anxiety.
Some cases in a very wide environment
In particular, to reach this decision, the risk pharmacy and assessment team (PRAC) took into account Data from the clinical trials of these drugs.
Thus, they identified themselves 325 Cases of suicide intention In most cases they refer to patients who have been treated with allopia, with these drugs.
These numbers were considered in the environment About 270 million years/patient’s expression The patient for finters and 82 million years/tatarida (indicates that each year/patient has taken medication for a year).
Notes
Emma. Medical Products with Finteride- and Tutasteride- recommendation. Advice online https://www.ema.europa.eu/en/medicines/human/referrals/finasteride-dutasteride-containg-medicinal-products May 8, 2025.
We’re already on WhatsApp! If you want to get all the current messages and the most important messages of the day, Click here and join our channel. It is a free, convenient and safe system.
